Evidence map›Paper›PMID 23998893›Full record

ReviewGenome medicine2013

Preimplantation genetic diagnosis guided by single-cell genomics.

Niels Van der Aa, Masoud Zamani Esteki, Joris R Vermeesch, Thierry Voet

Open access · goldAbstract readReview
In one paragraph

Review in Genome medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
10.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. The evolving role of genetic tests in reproductive medicine.Journal of translational medicine · 2019
    Review
  11. Haploseek: a 24-hour all-in-one method for preimplantation genetic diagnosis (PGD) of monogenic disease and aneuploidy.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. De Novo Paternal FBN1 Mutation Detected in Embryos Before Implantation.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Niels Van der AaLaboratory of Reproductive Genomics, Department of Human Genetics, KU Leuven, Leuven 3000, Belgium.
Masoud Zamani EstekiLaboratory of Reproductive Genomics, Department of Human Genetics, KU Leuven, Leuven 3000, Belgium.
Joris R VermeeschLaboratory of Cytogenetics and Genome Research, Department of Human Genetics, KU Leuven, Leuven 3000, Belgium.
Thierry VoetLaboratory of Reproductive Genomics, Department of Human Genetics, KU Leuven, Leuven 3000, Belgium ; Single-cell Genomics Centre, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
KU Leuven · BEWellcome Sanger Institute · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preimplantation genetic diagnosis (PGD) aims to help couples with heritable genetic disorders to avoid the birth of diseased offspring or the recurrence of loss of conception. Following in vitro fertilization, one or a few cells are biopsied from each human preimplantation embryo for genetic testing, allowing diagnosis and selection of healthy embryos for uterine transfer. Although classical methods, including single-cell PCR and fluorescent in situ hybridization, enable PGD for many genetic disorders, they have limitations. They often require family-specific designs and can be labor intensive, resulting in long waiting lists. Furthermore, certain types of genetic anomalies are not easy to diagnose using these classical approaches, and healthy offspring carrying the parental mutant allele(s) can result. Recently, state-of-the-art methods for single-cell genomics have flourished, which may overcome the limitations associated with classical PGD, and these underpin the development of generic assays for PGD that enable selection of embryos not only for the familial genetic disorder in question, but also for various other genetic aberrations and traits at once. Here, we discuss the latest single-cell genomics methodologies based on DNA microarrays, single-nucleotide polymorphism arrays or next-generation sequence analysis. We focus on their strengths, their validation status, their weaknesses and the challenges for implementing them in PGD.

Identifiers

PMID23998893
PMCPMC3979122
OpenAlexW2149207286

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.